These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 21892917)

  • 1. PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery.
    Milla P; Dosio F; Cattel L
    Curr Drug Metab; 2012 Jan; 13(1):105-19. PubMed ID: 21892917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylation: a successful approach to improve the biopharmaceutical potential of snake venom thrombin-like serine protease.
    da-Silva-Freitas D; Boldrini-França J; Arantes EC
    Protein Pept Lett; 2015; 22(12):1133-9. PubMed ID: 26458403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylation: a novel process for modifying pharmacokinetics.
    Harris JM; Martin NE; Modi M
    Clin Pharmacokinet; 2001; 40(7):539-51. PubMed ID: 11510630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in PEGylation of important biotech molecules: delivery aspects.
    Ryan SM; Mantovani G; Wang X; Haddleton DM; Brayden DJ
    Expert Opin Drug Deliv; 2008 Apr; 5(4):371-83. PubMed ID: 18426380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylation and its impact on the design of new protein-based medicines.
    Ginn C; Khalili H; Lever R; Brocchini S
    Future Med Chem; 2014; 6(16):1829-46. PubMed ID: 25407370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunogenicity of polyethylene glycol: facts and fiction.
    Schellekens H; Hennink WE; Brinks V
    Pharm Res; 2013 Jul; 30(7):1729-34. PubMed ID: 23673554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEG - a versatile conjugating ligand for drugs and drug delivery systems.
    Kolate A; Baradia D; Patil S; Vhora I; Kore G; Misra A
    J Control Release; 2014 Oct; 192():67-81. PubMed ID: 24997275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Membrane PEGylation on Entry and Location of Antifungal Drug Itraconazole and Their Pharmacological Implications.
    Dzieciuch-Rojek M; Poojari C; Bednar J; Bunker A; Kozik B; Nowakowska M; Vattulainen I; Wydro P; Kepczynski M; Róg T
    Mol Pharm; 2017 Apr; 14(4):1057-1070. PubMed ID: 28234487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylation, successful approach to drug delivery.
    Veronese FM; Pasut G
    Drug Discov Today; 2005 Nov; 10(21):1451-8. PubMed ID: 16243265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of PEGylation on biological therapies.
    Veronese FM; Mero A
    BioDrugs; 2008; 22(5):315-29. PubMed ID: 18778113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives.
    Gaballa SA; Shimizu T; Ando H; Takata H; Emam SE; Ramadan E; Naguib YW; Mady FM; Khaled KA; Ishida T
    J Pharm Sci; 2024 Mar; 113(3):555-578. PubMed ID: 37931786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of PEGylated Nanoparticles on Tumor Targeted Drug Delivery.
    Mozar FS; Chowdhury EH
    Curr Pharm Des; 2018; 24(28):3283-3296. PubMed ID: 30062957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Induction of Anti-PEG Immune Responses by PEGylation of Proteins].
    Shimizu T; Ishima Y; Ishida T
    Yakugaku Zasshi; 2020; 140(2):163-169. PubMed ID: 32009039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylation: an approach for drug delivery. A review.
    Jain A; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2008; 25(5):403-47. PubMed ID: 19062633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGYLATION: an important approach for novel drug delivery system.
    Yadav D; Dewangan HK
    J Biomater Sci Polym Ed; 2021 Feb; 32(2):266-280. PubMed ID: 32942961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of pegylated proteins.
    Fee CJ; Van Alstine JM
    Methods Biochem Anal; 2011; 54():339-62. PubMed ID: 21954785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG-modified biopharmaceuticals.
    Bailon P; Won CY
    Expert Opin Drug Deliv; 2009 Jan; 6(1):1-16. PubMed ID: 19236204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides.
    Remaut K; Lucas B; Braeckmans K; Demeester J; De Smedt SC
    J Control Release; 2007 Feb; 117(2):256-66. PubMed ID: 17188777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated nanocarriers for systemic delivery.
    Jain NK; Nahar M
    Methods Mol Biol; 2010; 624():221-34. PubMed ID: 20217599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.